Current Cancer Drug Targets
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
Journal Specifications
- PublisherBENTHAM SCIENCE PUBL LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year2000
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Current Cancer Drug Targets been publishing? 
The Current Cancer Drug Targets has been publishing since 2000 till date.
How frequently is the Current Cancer Drug Targets published?
Current Cancer Drug Targets is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Current Cancer Drug Targets?
Current Cancer Drug Targets has a H-index score of 99, Citescore of 6.4, SNIP score of 0.85, & SJR of Q2
Who is the publisher of Current Cancer Drug Targets?
The publisher of Current Cancer Drug Targets is BENTHAM SCIENCE PUBL LTD.
Where can I find a journal's aims and scope of Current Cancer Drug Targets?
For the Current Cancer Drug Targets's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Current Cancer Drug Targets on editage?
For the Current Cancer Drug Targets metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Current Cancer Drug Targets?
The eISSN number is 1873-5576 and pISSN number is 1568-0096 for Current Cancer Drug Targets.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Carcinogenesis, Assay, Chemotherapy, Lung cancer, Breast cancer, Reactive oxygen species, Autophagy, Immunotherapy, Cell activation, Colorectal cancer, Drug resistance, Temozolomide, Tumor growth, RNA editing, Prostate cancer, Hepatocellular carcinoma, Oxime, Tumor progression, Immune system.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.